C ardiac systolic stress is increased in cardiovascular diseases such as hypertension and myocardial infarction (MI), and this requires an increase in contractile Ca 2+ . Persistent pathological stress usually results in a Ca 2+ -dependent pathological hypertrophy with Ca 2+ -related contractility defects. Abnormal contractile Ca 2+ with depressed contractility reserve is a hallmark of cardiac hypertrophy and heart failure, 1 but this contractile Ca 2+ does not seem to be the source for activation of the signaling pathways that cause pathological hypertrophy. Recent data suggest that separate pools of myocyte signaling and contractile Ca 2+ are involved in the induction of hypertrophy. 2 The source and cellular location of the signaling Ca 2+ is still not clearly defined. The present study explores the hypothesis that the expression of transient receptor potential canonical (TRPC) channels are induced after MI, and Ca 2+ influx through these channels within specific microdomains is necessary for the development of pathological hypertrophy, as well as for affecting contractility reserve that ultimately contributes to impaired pump function of the diseased heart. 3, 4 The function of the TRP family of channels is not well understood in the heart, but it has been implicated in contributing to the initiation of pathological cardiac remodeling. 5-8 TRP channels are a class of nonselective cation influx channels that are grouped into 7 families 6,9 and are present in many
different cell types. 10 The TRPC family includes 7 isoforms (TRPC1-7) that have been divided into 2 general subfamilies based on structural and functional similarities: TRPC1/4/5 and TRPC3/6/7. 6 In general, TRPC3/6/7 are activated by diacylglycerol generated by G protein-coupled receptors/Gαq/ phospholipase C signaling, 11 whereas TRPC1/4/5 can be activated by stretch or depletion of intracellular Ca 2+ stores (store-operated Ca 2+ entry; SOCE) 12, 13 ; however, TRPC6 has also been implicated as a mechanosensing isoform as well. 14 Functional TRPC channels are formed as tetramers of individual 6-transmembrane spanning subunits. Interestingly, the channels can be homomeric or heteromeric assemblies with oligomerization occurring within and between subfamilies or beyond the TRPC family altogether (ie, TRPCs can oligomerize with TRPVs [transient receptor potential vanilloid] and TRPMs [transient receptor potential melastatin]). [15] [16] [17] [18] TRPC channels are expressed at very low levels in normal adult cardiac myocytes, but expression and activity of select isoforms seem to be increased in pathological hypertrophy and heart failure. 5, 7, 8, 19 TRPC channels have been suggested as initiators of Ca 2+ -dependent signaling that leads to pathological cardiac remodeling, hypertrophy, and failure. 5, 6 Transgenic cardiac-specific overexpression of TRPC3 or TRPC6 channels in mice causes re-expression of fetal genes, myocyte hypertrophy, and activation of apoptotic signaling. 7, 20, 21 The prohypertrophic effects of TRPC channels have also been shown in vitro in cultured cardiomyocytes. 5, 22 Studies involving loss of TRPC function suggest a necessary role for these channels in pathological hypertrophy. TRPC3 inhibition with the inhibitor Pyr3 blocks cardiac hypertrophy in mice subjected to pressure overload, 23 and this finding has been supported by data in gene-deleted mice (TRPC1 8 and TRPC3/6 24 ) and in mice expressing dominant-negative (dn) mutants of select channels (dnTRPC3,4,6). 21 Interestingly, mice expressing dnTRPC4 also inhibited the activity of the TRPC3/6/7 subfamily in the heart, which suggests that TRPC1/4/5 and 3/6/7 subfamilies function in coordinated complexes, at least when overexpressed. 21 The present study takes advantage of the dnTRPC strategy to define the role of TRPCs in post-MI structural and functional remodeling. Ca 2+ influx through TRPC channels was shown to activate the Ca 2+ -sensitive phosphatase calcineurin that initiates diverse intracellular responses through its downstream transcriptional effector, nuclear factor of activated T cells (NFAT). 12, 13, 15, 22 Calcineurin-NFAT (Cn-NFAT) signaling in the heart is a wellknown prohypertrophic pathway that is both necessary and sufficient for pathological growth. 3 Activation of this signaling cascade is thought to be the primary mechanism through which TRPC channels regulate cardiac hypertrophy. A recent in vitro study from our group suggests that TRPCs and l-type Ca 2+ channels (lTCC) work in a coordinated fashion to activate Cn-NFAT signaling. 22 Additional studies from our group showed that a subpopulation of lTCC localized specifically to caveolae membrane signaling microdomains is involved in pathological hypertrophic signaling. 25 The present study explores the hypothesis that TRPCs and lTCC function as essential partners in these caveolae signaling microdomains where their activity initiates hypertrophic Cn-NFAT signaling after MI.
The role of TRPC channels within excitation-contraction coupling microdomains has not been clearly defined. There are data in mice associating increased TRPC activity with reduced contractility 7, 20 and loss of TRPC function with increased contractility, 21 but the mechanisms underlying these effects are not understood. The present study explores the hypothesis that Ca 2+ influx through TRPC channels within excitation-contraction coupling microdomains results in reduced contractility reserve after MI.
Methods
See the extended Materials and Methods section in the Online Data Supplement. In brief, adult mouse and feline myocytes were isolated. [26] [27] [28] [29] TRPC-mediated Ca 2+ entry 20 and Ca 2+ spark activity were measured in unpaced myocytes loaded with Fluo-4, whereas pacing protocols were implemented for fractional shortening and Ca 2+ transient contractility studies. [26] [27] [28] [29] NFAT translocation studies were performed in adult feline myocytes (AFMs) using adenoviral-mediated expression of NFAT-GFP, 22, 25 and immunoprecipitation, sucrose density gradients, and Western blot analysis were used for membrane localization 25 and phosphorylation 30 studies. Animal procedures were approved by the Temple University Institutional Animal Care and Use Committee. We induced MI in mice by permanent occlusion of the left main coronary artery as previously described, 31 and animals were monitored during the course of the study using in vivo echocardiography. 30 
Results

TRPC Channel Expression and Activity Is Induced After MI
Individual TRPC channels are expressed at low levels in normal adult heart, but expression and activity of select isoforms are upregulated in pathological stress conditions. 3, [6] [7] [8] 19 We induced MI in mice as previously described 31 and measured the abundance of individual TRPC channel mRNA by reverse transcriptase polymerase chain reaction. MI resulted in the significant induction of hypertrophic gene markers and TRPC1/3/4/6 isoforms in mice 1, 2, and 6 weeks post-MI compared with sham animals ( Figure 1A ).
TRPC-mediated Ca 2+ influx was determined using a TRPC-mediated Ca 2+ entry bioassay. In most cell types, the depletion of intracellular Ca 2+ stores leads to the activation of SOCE through defined channel complexes that include STIM (stromal interaction molecule) and Orai and potentially TRPC channels on the plasma membrane. 32 Although the role of TRPC channels in SOCE in cardiac myocytes is not well defined, sarcoplasmic reticulum (SR) Ca 2+ depletion of isolated myocytes followed by the reintroduction of Ca 2+ in the presence of TRPC channel activator . Myocardial infarction induces transient receptor potential canonical (TRPC) channel expression and activity in mice, and overexpression of TRPC channels in feline myocytes leads to increased membrane Ca 2+ influx. A, Reverse transcriptase polymerase chain reaction shows an upregulation of TRPC1/3/4/6 channel isoforms at 1, 2, and 6 wks post-myocardial infarction (MI) along with the activation of the fetal gene program. B to D, TRPC-mediated Ca 2+ entry in isolated myocytes from sham mice (left) or 1 wk (B), 2 wk (C), or 6 wk (D) post-MI mice (right) in the presence of the TRPC channel agonist OAG (10 umol/L) and the sarcoplasmic reticulum Ca 2+ ATPase inhibitor cyclopiazonic acid (CPA; 5 umol/L). Where indicated, the TRPC antagonists SKF-96365 (5 umol/L), GSK503A (GSK; 10 umol/L), Pyr10 (3 umol/L), or the L-type Ca 2+ channel inhibitor nifedipine (Nif; 10 umol/L) were used. E, Adult feline myocytes infected with the indicated adenoviruses and assayed for TRPC-mediated Ca 2+ entry. P<0.05 was considered significant (ns, P>0.05, *P≤0.05, **P≤0.01, ***P≤0.001 vs sham). ANF indicates atrial natriuretic factor; BNP, brain natriuretic peptide; MHC, myosin heavy chain; and SMA, skeletal muscle actin.
1-oleoyl-2-acetyl-sn-glycerol (OAG), a stable cell-permeable analog to the known TRPC agonist diacylglycerol, is an approach that has been used to assess TRPC-mediated Ca 2+ entry. 6, 20 Myocytes isolated from mice 1, 2, or 6 weeks post-MI showed substantial TRPC-mediated Ca 2+ entry, whereas myocytes from sham animals showed no detectable activity ( Figure 1B-1D ). Similar results were seen in these MI myocytes in response to angiotensin II (Online Figure IA) . The specificity of TRPC-mediated Ca 2+ entry in MI myocytes was validated by inhibition with the pan TRPC antagonist SKF-96365 or the TRPC3/6-specific inhibitor GSK503A 24 ( Figure 1B-1D ). TRPC-mediated Ca 2+ entry was not inhibited by the lTCC antagonist nifedipine, documenting that this Ca 2+ entry is independent of lTCC-mediated Ca 2+ entry. Controls were also performed in cells incubated with cyclopiazonic acid alone, which resulted in a transient Ca 2+ entry in 6-week MI myocytes but no detectable entry in sham myocytes (Online Figure IB) and also with myocytes treated with OAG alone (Online Figure IC) , which resulted in Ca 2+ entry in MI myocytes only and led to spontaneous contractions.
AFMs Expressing TRPC Channels Have Increased Membrane Ca 2+ Influx
To further characterize the properties of TRPC channels in adult cardiac myocytes, we used cultured isolated AFMs because their electrophysiological and Ca 2+ regulatory properties more closely resemble those of human myocytes (in comparison to rodent myocytes). 33 AFMs survive in culture without the use of drugs that reduce Ca 2+ influence and overload. This allows for manipulation of protein expression using adenoviral vectors in an adult myocyte that maintains stable electric and mechanical properties. 27, [34] [35] [36] We performed TRPC-mediated Ca 2+ entry measurements in AFMs infected with adenovirus (Ad) for red fluorescent protein (RFP; control), TRPC3, TRPC4, TRPC6, or a dnTRPC4 or dnTRPC6. Because of their ability to hetero-oligomerize, the use of a dnTRPC4/6 effectively inhibits the activity of all TRPC subfamilies of channels 6, 21 (Online Figure II) . Ad-RFP-infected myocytes showed little or no TRPC-mediated Ca 2+ entry, whereas myocytes infected with Ad-TRPC3, TRPC4, or TRPC6 showed significant Ca 2+ entry, which was inhibited by the expression of Ad-dnTRPC4 or dnTRPC6 but unaffected by nifedipine ( Figure 1E ). TRPC-mediated Ca 2+ entry was inhibited by the pan TRPC antagonist SKF-96365 in TRPC3/4/6-infected cells, whereas the more targeted TRPC3/6 inhibitor GSK503A only inhibited TRPC-mediated Ca 2+ entry in TRPC3/6-infected cells. Similarly, the TRPC3 inhibitor Pyr10 37 was able to inhibit TRPC-mediated Ca 2+ entry in TRPC3-infected cells. Controls were also performed in cells incubated with cyclopiazonic acid alone, which resulted in a transient Ca 2+ entry in TRPC4-infected myocytes only but no detectable entry in control or TRPC3/6 expressing myocytes (Online Figure ID) . This is likely because of the ability of TRPC4 to participate in SOCE, whereas TRPC3/6 tends to be more agonist-induced channels. Similar to our findings in mouse myocytes, TRPC-infected AFMs treated with OAG alone (Online Figure IE 
TRPC Channel Overexpression in AFMs Enhances SR Ca 2+ in AFMs
TRPC3/6 overexpression in the adult mouse heart is linked to cardiac hypertrophy and depressed cardiac contractility. 7, 20 Myocyte contractions (fractional shortening) and Ca 2+ transients were measured in AFMs infected with Ad-RFP, -TRPC3, -TRPC4, -TRPC6 or -dnTRPC4 or -dnTRPC6 after periods of rest (Figure 2A -2C). One of the hallmark contractile characteristics of large mammalian myocytes, including AFMs, is a positive contractile staircase when stimulation is reinstated after a period of rest. 26, 38 AFMs, as well as those of other large mammals including humans, have a lower cytoplasmic [Na + ] than found in rodents. 34 This promotes forward-mode Na + / Ca 2+ exchange (NCX), which in the absence of pacing results in low cytoplasmic [Ca] 2+ and very small amounts of Ca 2+ stored in the SR. Therefore, in normal AFMs, the first post-rest contraction and Ca 2+ transient are small and then increase in subsequent beats as the SR is progressively loaded with Ca 2+ to a new steady state. After rest periods, control (Ad-RFP) AFMs showed a beat-dependent increase in their contractions and Ca 2+ transients ( Figure 2A ). Conversely, the first post-rest beat in Ad-TRPC3, -TRPC4, or -TRPC6-infected cells was larger and similar to the steady-state contraction. Intracellular Ca 2+ was elevated in Ad-TRPC3, -TRPC4, and -TRPC6-infected cells compared with Ad-RFP cells as evidenced by increased fractional shortening (Figure 2A and 2B) and increased Ca 2+ transient amplitude (F/F0; Figure 2A and 2C) in the first paced contraction after a nonpaced interval. These TRPC-mediated effects on rested state contractions and Ca 2+ transients were inhibited by coexpression with dnTRPC4 or dnTRPC6 ( Figure 2 ; Online Figure III ). These results suggest that Ca 2+ influx through TRPC channels maintains SR Ca 2+ stores in the absence of lTCC-mediated Ca 2+ entry, supporting a role for TRPC-mediated Ca 2+ entry in disease when the normal A C D B Figure 3 . Transient receptor potential canonical (TRPC) channels induce sarcoplasmic reticulum Ca 2+ leak and spark activity in adult feline myocytes (AFMs) and lead to a reduction in contractility reserve. A, Representative serial confocal images taken to detect spontaneous Ca 2+ spark events in AFMs infected with the indicated adenoviruses at baseline or with OAG treatment. Scale bar is 5 μm. Fluorescence intensity of Fluo-4 signal is indicated in a scale of arbitrary units (f.a.u.). KN93 was used at 10 umol/L. B, Spark events were quantified and average data of n=20 cells (ns, P>0.05; ***P≤0.001 vs red fluorescent protein [RFP] control; #P≤0.05, ##P≤0.01 vs TRPC3, &P≤0.05, &&P≤0.01 vs TRPC6). C, Average fractional shortening data and peak Ca 2+ transients (D) from AFMs infected with the indicated adenovirus at baseline and after exposure to isoproterenol (Iso). P<0.05 was considered significant with *P≤0.05 vs RFP control; #P≤0.05 or ##P≤0.01 vs baseline of same experimental group.
pathway for Ca 2+ influx (through lTCC) is reduced and the SR Ca 2+ load is diminished, although the nondiseased adult heart probably does not use this pathway because TRPC channels are not appreciably expressed.
Ca 2+ Influx Through TRPC Channels Induces Ca 2+ Spark Activity in AFMs
TRPC3/4/6 expressing AFMs had enhanced Ca 2+ influx at rest that promotes SR Ca 2+ loading, but steady-state contractions were not increased. Therefore, we tested the idea that persistent Ca 2+ influx through TRPC can lead to excess spontaneous SR Ca 2+ release (SR Ca 2+ leak). Spontaneous Ca 2+ sparks were measured to address this idea. 39 Ca 2+ sparks are local spontaneous Ca 2+ release events caused by the opening of a cluster of ryanodine receptor (RyR) channels in the absence of lTCC opening. 40, 41 These events are common in quiescent rodent myocytes because of their high [Na + ] that promotes Ca 2+ entry via reverse-mode NCX activity culminating in SR Ca 2+ overload. 34, 42 As discussed above, AFMs maintain low [Na] 2+ , and they do not exhibit Ca 2+ accumulation or spontaneous SR Ca 2+ release in long-term culture. 34 We infected AFMs with Ad-RFP (control), -TRPC3, -TRPC6, -TRPC3 and -dn-TRPC6, or -TRPC6 and dnTRPC4 and measured Ca 2+ spark activity in the presence and absence of the TRPC channel agonist OAG. Control myocytes rarely exhibited Ca 2+ sparks but did show a low level of Ca 2+ spark activity with the addition Figure 3A and 3B). AFMs infected with TRPC3 or TRPC6 showed robust Ca 2+ spark activity under baseline conditions, and this was increased further with OAG stimulation. The majority of detectable Ca 2+ spark activity was blocked by dnTRPC6, even in the presence of OAG. TRPC3-or TRPC6mediated Ca 2+ spark activity was also significantly inhibited by the Ca 2+ /calmodulin protein kinase II (CaMKII) inhibitor KN93, suggesting that this process may in part result from local activation of CaMKII and phosphorylation of RyR 2 . To address this issue, we measured phosphorylation of RyR at S2814, which is a CaMKII phosphorylation site, in AFMs infected with TRPC3±dnTRPC6 and ±OAG ( Figure 4A-4C ) or TRPC6±dnTRPC4 and ±OAG (Online Figure IV) . These experiments show that TRPC3 and TRPC6 induce RyR S2814 and phospholamban T17 phosphorylation ( Figure 4C and 4F) without modifying RyR S2808 or phospholamban S16 phosphorylation ( Figure 4B and 4E) or total RyR or phospholamban expression ( Figure 4D and 4G ). OAG-mediated increases in RyR S2814 and phospholamban T17 phosphorylation was reduced by CaMKII inhibition (KN93; Figure 4C and 4F; Online Figure IV ). We also found that TRPC3 or TRPC6 expression in AFMs was associated with diminished contractile response to catecholamines as evidenced by a reduction in maximal amplitude of fractional shortening and peak Ca 2+ transients in the presence of isoproterenol ( Figure 3C and 3D ).
TRPC Channels Localize to Caveolae Where Their Organization Is Essential for Hypertrophic Signaling
Previous work from our group showed that Ca 2+ influx through both TRPCs and lTCC contributes to the activation of Cn-NFAT signaling and indicated that there may be a potential interaction between the channels. 22 This interaction might take place within subcellular signaling microdomains such as caveolae, 25 and it is known that nearly all TRPC isoforms contain a putative caveolin-binding motif. 43 To explore this further, we characterized the biochemical interactions between TRPCs, lTCC, and caveolin-3, the major structural protein of myocyte caveolae, using immunoprecipitation with purified plasma membranes from isolated ventricular myocytes of dnTRPC4 transgenic mice ( Figure 5A ) or AFMs infected with a FlAGtagged version of TRPC6 (Ad-TRPC6-FlAG; Online Figure  VA ). Our immunoprecipitation data show that caveolin-3, lTCC, and TRPC channels are all complexed together in caveolae. This was further substantiated using sucrose density gradient fractionation of plasma membrane preparations from AFMs infected with Ad-TRPC3 ( Figure 5B ). To examine the functional relevance of TRPC channels localized to caveolae, we assessed their role in pathological hypertrophic signaling using an NFAT-GFP reporter assay. 25, 44 AFMs were infected with Ad-NFAT-GFP and either Ad-RFP (control), -TRPC3, -TRPC4, -TRPC6, -TRPC3 and -dnTRPC6, or -TRPC6 and -dnTRPC4. Essentially all of the NFAT-GFP was localized to the cytoplasm in control AFMs (Figure 5C and 5D ). Ad-TRPC3, -TRPC4, and -TRPC6-infected cells showed a small but significant increase in baseline nuclear NFAT signal, which was inhibited by coinfection with dnTRPC6 or dnTRPC4 ( Figure 5C and 5D; Online Figure VI) . Exposing myocytes to OAG caused a very slight increase in NFAT translocation in control cells and a significant increase in nuclear NFAT in TRPC3-or TRPC6-infected cells ( Figure 5C and 5D ). Incubating TRPC4-infected cells with high Ca 2+ (4 mmol/l) also led to a significant increase in NFAT translocation (Online VIC). The TRPC3/4/6 effect was eliminated with coinfection with dnTRPC6 or dnTRPC4 ( Figure 5C and 5D ). To further assess whether organizing Ca 2+ influx pathways in caveolae is essential for NFAT regulation, we subjected myocytes to treatment with methyl-β-cyclodextrin, which disrupts caveolae by depleting cholesterol and displaces the macromolecular signaling complexes usually organized in caveolae microdomains (Online Figure V) . Methyl-βcyclodextrin inhibited TRPC3/4/6-mediated NFAT nuclear translocation in the presence of OAG or high Ca 2+ (Figure 5C and 5D; Online Figure VI ), suggesting that the organization of lTCC and TRPC channels together in caveolae signaling microdomains is necessary for them to activate hypertrophic signaling.
A previous study from our group characterized a caveolae-targeted lTCC inhibitor, Rem 1-265 -Cav, which could specifically inhibit lTCC with caveolin-3 microdomains, to reduce NFAT nuclear translocation without affecting contractility. 25 When we coinfected NFAT-GFP-expressing AFMs with Ad-TRPC3 and -Rem 1-265 -Cav and treated these cells with OAG, we saw a significant inhibition of NFAT translocation ( Figure 5C and 5D ). These results suggest that TRPC channels and lTCC housed together in caveolae membrane microdomains provide a source of Ca 2+ that induces calcineurin activation and nuclear NFAT translocation.
TRPCs are relatively nonselective cation channels that allow both Na + and Ca 2+ entry. Others have shown that Na + entry through the Na + /H + exchanger (NHE-1) increases local Ca 2+ via NCX, leading to NFAT activation. 45, 46 Using both caveolin-3 immunoisolations and sucrose density gradients, we found the presence of both NHE-1 and NCX in caveolae membrane microdomains (Online Figure VII) . To look specifically at a functional role for NHE-1 in our model, we performed NFAT-GFP assay in TRPC3/4/6 in the presence of the NHE-1 inhibitor cariporide (Online Figure VID) and found that there was no effect on NFAT translocation in these cells. These data suggest that although NHE-1 colocalizes with TRPC, it is not contributing to TRPC-mediated NFAT activation under our conditions. 
Loss of TRPC Function Protects Against Cardiac Dysfunction Progression After MI and Improves Survival
After MI, myocytes develop pathological hypertrophy, myocyte function is altered, and TRPC channel expression increases. Overexpression of TRPC channels in the mouse heart is sufficient to induce hypertrophy and cardiomyopathy, 5, 7, 20 and mice expressing dominant-negative versions of the channel have less hypertrophy in response to pressure overload or neuroendocrine agonist infusion. 8, 21 Taken together with our in vitro findings, these data support the idea that inhibiting TRPC function in the heart could be beneficial after MI. To test this idea, we used a transgenic mouse with cardiac-specific expression of a truncated dnTRPC4 21 that reduces the activity of both the TRPC1/4/5 and TRPC3/6/7 subfamilies of TRPC channels. 21 TRPC mRNA levels were not significantly different between wild-type (WT) and dnTRPC4 mice both in sham and MI groups ( Figure 6 ; Online Figure VIII) with the exception of TRPC4, which was markedly increased in dn-TRPC4 animals because of overexpression of the transgene. TRPC-mediated Ca 2+ entry seen in WT 6-week MI myocytes, which could be partially inhibited by the selective TRPC3/6 antagonist GSK503A or the TRPC3 inhibitors Pyr3 or Pyr10 or completely inhibited with SKF-96365, was not present in dnTRPC4 mice ( Figure 6 ). Echocardiography measurements revealed a slightly increased baseline ejection fraction in dnTRPC4 mice compared with WT animals (75.5% versus 68.2%; Figure 7A and 7B), consistent with the inotropic effects of dnTRPC6 observed in AFMs. The area at risk after MI was identical in WT and dnTRPC4 mice (41.3±3.8% versus 43.5±4.9%; Online Figure IIIA ). Infarct length measured 3 weeks after MI was not significantly different in dnTRPC4 than in WT mice (dnTRPC4 versus WT: 28.7±1.7% versus 33.2±0.9%; Online Figure IXB ). In addition, the dilation seen in WT mice 3 weeks post-MI was attenuated in dnTRPC4 hearts (Online Figure IXC andn IXD) . Serial echocardiography was used to measure left ventricular structure and function after MI. WT (ejection fraction: sham versus MI, 68.2% versus 37.2%) and dnTRPC4 (ejection fraction: sham versus MI, 75.5% versus 41.8%) animals had equivalent reductions in cardiac pump function 2 weeks after MI ( Figure 7B ). left ventricular function remained depressed at 6 weeks post-MI in WT animals, whereas there was a significant improvement in cardiac pump function in dnTRPC4 hearts 6 weeks after MI ( Figure 7A and 7B ).
There were significant pathological changes in ventricular geometry and wall thickness in all hearts after MI ( Figure 7C and 7D). The magnitude of these changes increased with time in WT animals but was attenuated in dnTRPC4 mice. After MI, posterior wall thickness was decreased in both WT and dnTRPC4 hearts (WT pre-MI versus post-MI: 0.97 versus 0.87 mm; dnTRPC4: 1.06 versus 0.84 mm; Figure 7C ). At 6 weeks post-MI, posterior wall thickness returned to values near pre-MI levels (or close to shams) in dnTRPC4 hearts, whereas posterior wall thickness remained thinner in WT hearts. All hearts showed some evidence of dilation after MI; however, left ventricular internal diameter increased significantly more in WT than in dnTRPC4 hearts in the first 2 weeks after MI (WT pre-MI versus post-MI: 3.8 versus 4.9 mm; dnTRPC4: 3.7 versus 4.5 mm; Figure 7D ). By 6 weeks post-MI, left ventricular internal diameter was significantly more dilated in WT hearts than in dnTRPC4 (WT versus dn-TRPC4: 5.3 versus 4.8 mm). dnTRPC4 mice had significantly greater survival after MI (53.7%) than WT animals (27.5%) during the 6-week post-MI study period ( Figure 7E ). Heart weight/body weight and lung weight/body weight were significantly increased ( Figure 7F and 7G) in WT versus dnTRPC4 mice 6 weeks post-MI. There were minimal changes in liver weight/body weight ratio before and after MI, and there was no significant difference between dnTRPC4 and WT mice (Online Figure IXE) . Dephosphorylation of NFAT induces cytoplasmic to nuclear translocation. Six-week MI dnTRPC4 mice had increased levels of phosphorylated NFAT as compared with WT 6-week MI mice, indicating reduced NFAT dephosphorylation in dn-TRPC4 mice (Online Figure XA-XC) . In accordance with this, isolated myocytes from 2-and 6-week post-MI WT had significantly greater length and width than in dnTRPC4 mice (Online Figure XD and XE) . Collectively, these results show that dnTRPC4 animals have less pathological remodeling after MI, improved cardiac pump function, and enhanced survival.
Myocytes From dnTRPC4 Mice Retain Their Hypercontractile Phenotype After MI
One potential mechanism for improved cardiac function after MI in dnTRPC4 versus WT hearts is that myocyte function and adrenergic responsiveness are better preserved. To address this idea, we first measured twitch contractions and [Ca] 2+ i transients in the absence and presence of isoproterenol in dnTRPC4 and WT myocytes after sham or MI procedures. Representative data are shown in Online Figure XIA and XIB. Fractional shortening of dnTRPC4 was significantly greater than in WT (sham) myocytes (dnTRPC4 versus WT: 11.0±0.6% versus 8.4±0.6%; Figure 8A ). After MI, contractions remained significantly greater in dnTRPC4 than in WT myocytes (dnTRPC4 versus WT: 13.4±1.1% versus 8.9±0.4%).
Myocyte contractions in both WT and dnTRPC4 cells increased with isoproterenol (WT sham±isoproterenol: 8.4±0.6% versus 11.7±0.8%; dnTRPC4 sham±isoproterenol: 11.0±0.6% versus 13.5±0.6%) with baseline contractions in dnTRPC4 being greater than in WT ( Figure 8A ). Post-MI, dnTRPC4 myocytes again had greater baseline contractions and isoproterenol response than WT myocytes (post-MI WT±isoproterenol: 8.9±0.4% versus 13.0±0.4%; post-MI dnTRPC4±isoproterenol: 13.4±1.1% versus 16.0±0.8%).
Peak systolic [Ca] 2+ i in dnTRPC4 (sham) myocytes was significantly greater than in WT myocytes ( Figure 8B ), explaining their greater twitch contractions. After MI, [Ca] 2+ i transients in dnTRPC4 myocytes remained significantly greater than in WT myocytes (peak F/F 0 in dnTRPC4 sham versus WT sham: 3.0±0.3 versus 2.1±0.3; post-MI dnTRPC4 versus WT: 3.6±0.5 versus 2.5±0.2). Isoproterenol significantly increased Ca 2+ Figure 8B ).
Contraction half width and the time constant of decay (Tau) of [Ca] 2+ i transients were also measured. Half width (±isoproterenol conditions) was significantly less in dnTRPC4 (sham) versus WT (sham) myocytes (dnTRPC4 [sham]±isoproterenol: 220±11 versus 209±9 ms; WT [sham]±isoproterenol: 280±20 versus 261±17 ms; Figure 8C ). MI induced changes (half width increase) in the duration of contractions in both dnTRPC4 and WT myocytes. After MI, half width of contractions (±isoproterenol conditions) remained significantly less in dnTRPC4 versus WT myocytes (dnTRPC4 [MI]±isoproterenol: 247±16 versus 230±14 ms; WT [MI]±isoproterenol: 315±15 versus 279±11 ms; Figure 8C ). Isoproterenol induced significant decreases in Tau in both WT and dnTRPC4 myocytes after sham or MI ( Figure 8D ). There were no significant differences in Tau between WT and dnTRPC4 myocytes after sham or MI±isoproterenol conditions ( Figure 8D ). Collectively, these data show that myocytes from dnTRPC4 MI hearts retain a hypercontractile phenotype after MI.
LTCC Current (I Ca,L ) Was Not Different Between dnTRPC4 and WT Myocytes After Sham or MI
Altered function of lTCC and loss of adrenergic regulation is a common feature of diseased cardiac myocytes. 47 We next examined if loss of TRPC function influenced the behavior of lTCC either before or after MI. lTCC currents were measured in single isolated myocytes from WT and dnTRPC4 hearts with or without MI. I Ca,l density was not significantly different in sham dnTRPC4 versus WT myocytes (peak I Ca,l in dnTRPC4 versus WT: −13.0±1.4 versus −12.1±0.85 pA/pF; Figure 8E ). Isoproterenol increased I Ca,l density in both sham dnTRPC4 myocytes (pre-isoproterenol versus after isoproterenol: −13.0±1.4 versus −22.5±2.8 pA/pF) and sham WT myocytes (−12.1±0.85 to −20.9±1.9 pA/pF). After MI, I Ca,l density was decreased to a similar extent in all myocytes (dnTRPC4 versus WT: −11.8±1.7 versus −10.4±1.1 pA/pF; Figure 8E ). However, only dnTRPC4 myocytes showed a significant increase in I Ca,l with isoproterenol after MI (pre-isoproterenol versus after isoproterenol: −11.8±1.7 versus −18.3±2.5 pA/ pF). Cell capacitance ( Figure 8F ) and cell size (Online Figure  XD and XE) were similar in sham WT and dnTRPC4 animals, but a significant increase in cell capacitance was seen in WT cells after MI ( Figure 8F ) but not in dnTRPC4 myocytes.
Discussion
This study explored the idea that Ca 2+ influx through TRPC channels expressed after MI contributes to altered myocyte contractility and hypertrophic signaling. Our studies revealed a low level of TRPC isoform expression in normal adult mouse and AFMs, with a significant increase in select TRPC isoform expression after MI (Figure 1 ). TRPC was shown to induce SOCE, which was abolished with a dnTRPC6-expressing adenovirus. Using AFMs, we showed that Ca 2+ entry through TRPC3 could load the SR when SR Ca 2+ stores were naturally depleted but could overload the SR and cause spontaneous SR Ca 2+ release (Ca 2+ sparks, leak) if SOCE was persistent or excessive, and these effects seem to be because of CaMKII-mediated RyR S2814 phosphorylation (Figure 4 ). TRPC expression was associated with reduced contractile effects of catecholamines. Our studies also showed that a fraction of TRPC channels is localized to caveolae, where together with lTCCs they activate pathological hypertrophic signaling. Finally, mice with cardiac myocyte−specific expression of dn-TRPC4 had less cardiac dysfunction and adverse remodeling after MI.
TRPC Expression in Disease
A clear link between Ca 2+ influx and cardiac hypertrophy has been established, 1, 48 and activation of Cn-NFAT signaling is known to initiate the coordinated expression of maladaptive hypertrophic genes, and overstimulation of this pathway can lead to heart failure. 3, 49, 50 Multiple in vitro 5, 22, 24, 51, 52 and in vivo 7, 20, 21, 51, 53 TRPC expression systems have documented a role for these channels in the induction of Cn-NFAT signaling and subsequent hypertrophic remodeling. TRPC loss-offunction 6, 8, 21, 24, 54 and selective inhibition 23, 24, 53 animal models are protected against cardiac hypertrophy and indices of heart failure after either pressure overload or neurohormonal stress. In accordance with these studies, we found that cardiac-specific overexpression of dnTRPC4 resulted in reduced pathological remodeling in an MI model of injury (Figure 7) and a cardioprotective phenotype that increased survival post-MI.
TRPC, SOCE, and Myocyte Contractility
Progressive deterioration of cardiac contractility is a central feature of heart failure, and alterations of intracellular Ca 2+ regulation are primarily responsible for this depression in contractility reserve. 1, 47 In this study, we explored the hypothesis that TRPC channels expressed in diseased myocytes contribute to their deteriorating contractility. Others have found that cardiac-specific overexpression of TRPC6 in mice resulted in an exaggerated hypertrophic response to pressure overload with decreased systolic function, 7 and a similar study showed that TRPC3 transgenic mice developed a loss of ventricular performance with profound cardiomyopathy. 20 We found enhanced cardiac pump function in cardiac-specific dnTRPC4 mice ( Figure 7A and 7B ) and increased myocyte fractional shortening and peak Ca 2+ transients ( Figure 8A and 8B) . These are somewhat curious findings, because TRPC is a pathway for Ca 2+ influx, and this would be expected to increase rather than decrease contractile Ca 2+ . To examine if/how TRPC channels cause alterations in myocyte contractility, TRPC3, TRPC4, TRPC6 or dnTRPC6 and dnTRPC4 were expressed in AFMs. We found that the changes in AFM contractile function were dependent on the experimental conditions. When normal or RFP-infected AFMs were unpaced for a period of time, their SR Ca 2+ stores became depleted (Figure 2A-2C ). TRPC3/4/6 expression resulted in enhanced rested-state contractions (Figure 2A-2C ), suggesting that when SR Ca 2+ stores are depleted, TRPC channels can supply Ca 2+ for refilling. However, in paced AFMs, TRPC3/6 resulted in reduced steady-state contractile function and reduced responsiveness to catecholamines ( Figure 3C ). TRPC3/6 overexpression induced Ca 2+ sparks ( Figure 3A and 3B ), suggesting that altered contractility was because of enhanced SR Ca 2+ leak. Finally, we showed that increased TRPC3/6 activity was associated with RyR S2814 phosphorylation that was reduced by CaMKII inhibition (Figure 4A and 4C) . These results suggest that although Ca 2+ influx through TRPC channels can replenish depleted SR Ca 2+ stores, excess TRPC channel activity causes local activation of CaMKII and phosphorylation of RyR at S2814, resulting in abnormal RyR function, producing spontaneous diastolic SR Ca 2+ release leading to depressed contractility reserve.
TRPC and Hypertrophy Signaling
Many groups have shown that TRPC channels contribute to the activation of Cn-NFAT signaling and hypertrophic response. 6, 21, 22, 55 Data from our study are in accordance with this and expand on what is known to show that the organization of TRPC channels along with lTCC in caveolae membrane microdomains influences their ability to orchestrate Cn-NFAT signaling. TRPC channels are known to allow influx of both Na + and Ca 2+ , and it has been shown by others that Na + entry via NHE-1 and induce Ca 2+ entry via the NCX to activate NFAT activation. 45, 46, 56 We found both NHE-1 and NCX in caveolae membrane microdomains (Online Figure VII) , suggesting that they could contribute to TRPC-mediated NFAT activation in these signaling microdomains. We addressed this by inhibiting NHE-1 with cariporide (Online Figure VID) but saw no change in TRPC-mediated NFAT nuclear translocation, indicating that NHE-1 is not playing a central role in this process in our system. However, our experimental design is unable to definitively rule out a role for Na + in this process, and it is possible that TRPC-mediated Na + entry is also a contributing factor to Cn-NFAT.
TRPC Inhibition Post-MI
Finally, an in-depth characterization of an MI model of injury in dnTRPC4 transgenic mice was used to determine if reducing TRPC channel activity after MI reduced structural and functional remodeling and had a beneficial outcome. We found that dnTRPC4 mice did not exhibit TRPC-mediated Ca 2+ entry after MI and had less pathological hypertrophy, better cardiac performance, less progression of heart failure, and increased survival after MI compared with WT animals (Figures 6 and 7 ; Online Figures IX and X) .
Collectively, our studies show that TRPC channels are stress-response molecules that are upregulated in chronic cardiac disease states. Mechanistically, our data suggest that TRPC channels disrupt normal SR Ca 2+ storage by inducing SR Ca 2+ leak to contribute to depressed contractility reserve in disease. These effects are accompanied by coordinated Ca 2+activated Cn-NFAT signaling through caveolae membrane microdomains. These data suggest that targeted inhibition of cardiac myocyte TRPC channels might be an effective strategy for attenuating pathological structural remodeling and for maintaining contractility reserve after MI. 
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